Literature DB >> 19034337

Bilharziasis and bladder cancer: a time trend analysis of 9843 patients.

Iman Gouda1, Nadia Mokhtar, Dalia Bilal, Tarek El-Bolkainy, Nabil M El-Bolkainy.   

Abstract

OBJECTIVE: To explore any changes in bladder carcinoma during 37 years period, in regard to: its frequency, bilharzia association, histological profile and demographic data. PATIENTS AND METHODS: This is a retrospective study on 9843 patients treated at the National Cancer Institute (NCI), Cairo University, during the years 1970-2007. Three groups were selected: series (A) included 3212 patients during 1970-1974, series (B) 3988 patients during 1985-1989 and series (C) 2643 patients during 2003-2007. For statistical analysis, data of series (A), (B) and (C) were compared to determine the significance of difference (p value 0.005).
RESULTS: A significant decline of the relative frequency of bladder cancer was observed from 27.63% in the old series to 11.7% in the recent series. Bilharzia association dropped from 82.4% to 55.3%. There was a significant rise of transitional cell carcinomas from 16.0% to 65.8%, becoming at present the most common tumor type, with a significant decrease in squamous cell carcinomas from 75.9% to 28.4%. There was an increase in the median age of patients from 47.4 years to 60.5 years and a decrease of male: female (M/F) ratio from 5.4 to 3.3.
CONCLUSIONS: The decline in the relative frequency of bladder cancer is associated with a decline in bilharzia egg positivity in the specimen and is probably related to better control of bilharziasis in the rural population in Egypt. This was accompanied by a change in the histological profile of tumors, with significant predominance of transitional cell carcinoma and an increase in the age of patients, a pattern rather similar to that in western reports.

Entities:  

Mesh:

Year:  2007        PMID: 19034337

Source DB:  PubMed          Journal:  J Egypt Natl Canc Inst        ISSN: 1110-0362


  24 in total

1.  Clinical profile, BRCA2 expression, and the androgen receptor CAG repeat region in Egyptian and Moroccan male breast cancer patients.

Authors:  Samuel F Gilbert; Amr S Soliman; Mehdi Karkouri; Meaghen Quinlan-Davidson; Ashley Strahley; Mohab Eissa; Subhojit Dey; Ahmed Hablas; Ibrahim A Seifeldin; Mohamed Ramadan; Noureddine Benjaafar; Kathy Toy; Sofia D Merajver
Journal:  Breast Dis       Date:  2011

2.  Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: a randomized phase II trial-an update.

Authors:  Rasha Haggag; Kamel Farag; Fouad Abu-Taleb; Sameh Shamaa; Abdel-Rahman Zekri; Tarek Elbolkainy; Hussein Khaled
Journal:  Med Oncol       Date:  2013-12-12       Impact factor: 3.064

3.  Vascular endothelial growth factor, p53, and the H-ras oncogene in Egyptian patients with bladder cancer.

Authors:  Farha A El-Chennawi; Fatma A Auf; Shereen S Metwally; Youssef M Mosaad; Atallah A Shaaban; Mahmoud Abdo El-Baz; Ziyad E Tawhid; Zakaria F Lotfy
Journal:  World J Gastrointest Oncol       Date:  2009-10-15

4.  Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients.

Authors:  Samuel F Gilbert; Amr S Soliman; Maria Iniesta; Mohab Eissa; Ahmed Hablas; Ibrahim A Seifeldin; Ashley Strahley; Mousumi Banerjee; Sofia D Merajver
Journal:  Breast Cancer Res Treat       Date:  2011-04-20       Impact factor: 4.872

5.  Diagnostic and Prognostic Significance of Serum and Tissue Galectin 3 Expression in Patients with Carcinoma of the Bladder.

Authors:  Hoda El Gendy; Bothina Madkour; Sara Abdelaty; Fayza Essawy; Dina Khattab; Olfat Hammam; Hani H Nour
Journal:  Curr Urol       Date:  2014-08-20

6.  Urinary bladder cancer in yemen.

Authors:  Abdullah Saleh Al-Samawi; Saleh Mansoor Aulaqi
Journal:  Oman Med J       Date:  2013-09

7.  Agricultural workers and urinary bladder cancer risk in Egypt.

Authors:  Sania Amr; Rebecca Dawson; Doa'a A Saleh; Laurence S Magder; Nabiel N Mikhail; Diane Marie St George; Katherine Squibb; Hussein Khaled; Christopher A Loffredo
Journal:  Arch Environ Occup Health       Date:  2014       Impact factor: 1.663

Review 8.  Linking Environmental Exposures to Molecular Pathogenesis in Non-Hodgkin Lymphoma Subtypes.

Authors:  Leah Moubadder; Lauren E McCullough; Christopher R Flowers; Jean L Koff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-07-29       Impact factor: 4.254

9.  Immunohistochemical expression of COX2 and iNOS in bladder cancer and its association with urinary schistosomiasis among Sudanese patients.

Authors:  Hassan Elsiddig Hassan; Ahmed Abdel Badie Mohamed; Amel Omer Bakhiet; Hussain Gadelkarim Ahmed
Journal:  Infect Agent Cancer       Date:  2013-02-15       Impact factor: 2.965

10.  Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients.

Authors:  Peter Fabian Rambau; Philipo L Chalya; Kahima Jackson
Journal:  Infect Agent Cancer       Date:  2013-05-24       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.